Dialogue 2: The Way Forward – Balancing Health Priorities in the Post-COVID-19 Era to Sustain Progress in Cancer Care

Research event Recording
30 July 2020 — 1:00PM TO 2:00PM

This event is the second discussion in the Chatham House Virtual Policy Dialogues: Maintaining Progress in Cancer Care series and will be followed by meetings on balancing health priorities in the post-COVID19 era and applying learnings from COVID-19 to strengthen and sustain cancer care. This series of events is sponsored by Merck Sharp & Dohme Corporation (MSD).

As COVID-19 continues to challenge health and economic systems around the world, the high value that communities ascribe to the health of individuals is being starkly illustrated. There is now greater recognition of the devastation that uncontrolled diseases can cause and the strain that these diseases place not only on health systems, but the patients that need them and the governments that fund them.

The ‘all at once’ nature of the pandemic and the necessarily urgent societal and governmental reactions to it, brings a sharp contrast to the same types of trade-off health funding decisions that are routinely made in many countries every day.

Recent advances in cancer prevention and development of innovative therapies have changed the landscape of cancer care, and governments have worked to capture the benefits of these innovations – from the development of robust National Cancer Control Plans to the establishment of financing mechanisms such as the United Kingdom’s Cancers Drug Fund or Italy’s innovation fund.

In countries that have made significant progress in cancer care, how can we ensure this progress is not lost in the post-COVID-19 era? The Centre for Universal Health at Chatham House is bringing together a diverse selection of health sector representatives for this series, including policymakers, clinicians, academics, patient groups, and the private sector.

In Dialogue 2 we will examine how can countries sustain momentum in cancer care and protect cancer funding in the face of competing health priorities. How can countries make strategic choices to achieve greater value for their money?


Princess Dina Mired of Jordan, President, Union for International Cancer Control

Philippe Drouet, Senior Vice President, Oncology Global Marketing & Market Access, MSD

André Ilbawi, Medical Officer, Cancer Control, World Health Organization

Chair: Robert Yates, Director, Global Health Programme; Executive Director, Centre for Universal Health, Chatham House

Support us

Donate today to help secure our future as the home of independent thinking, or join our international network as a member.

Find out more Auto insert on research events